| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario
|
Farswan, Akanksha
|
|
|
14 |
9 |
p.
|
artikel
|
| 2 |
Capitalizing on ATRX loss in glioma via PARP inhibition: Comment on “Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity” by Garbarino et al.
|
Zalenski, Abigail A
|
|
|
14 |
9 |
p.
|
artikel
|
| 3 |
Clinicopathological characteristics of androgen receptor splicing variant 7 (AR-V7) expression in patients with castration resistant prostate cancer: A systematic review and meta‐analysis
|
Li, Qinchen
|
|
|
14 |
9 |
p.
|
artikel
|
| 4 |
Comment on: A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma
|
Baidoun, Firas
|
|
|
14 |
9 |
p.
|
artikel
|
| 5 |
Comment on “comparative analysis of triple-negative breast cancer transcriptomics of Kenyan, African American and Caucasian women” by Saleh et al.
|
Brody, James P.
|
|
|
14 |
9 |
p.
|
artikel
|
| 6 |
Diagnostic assessment of deep learning for melanocytic lesions using whole-slide pathological images
|
Ba, Wei
|
|
|
14 |
9 |
p.
|
artikel
|
| 7 |
Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research
|
Negri, Francesca
|
|
|
14 |
9 |
p.
|
artikel
|
| 8 |
Immune checkpoint blockade impairs immunosuppressive mechanisms of regulatory T cells in B-cell lymphoma
|
Bauer, Vera
|
|
|
14 |
9 |
p.
|
artikel
|
| 9 |
Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
|
Cho, Kyung Joo
|
|
|
14 |
9 |
p.
|
artikel
|
| 10 |
Knockdown of CDK5 down-regulates PD-L1 via the ubiquitination-proteasome pathway and improves antitumor immunity in lung adenocarcinoma
|
Gao, Lin
|
|
|
14 |
9 |
p.
|
artikel
|
| 11 |
Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity
|
Garbarino, Jennifer
|
|
|
14 |
9 |
p.
|
artikel
|
| 12 |
PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor
|
Koga, Satoko
|
|
|
14 |
9 |
p.
|
artikel
|
| 13 |
Regulation of CD47 expression by interferon-gamma in cancer cells
|
Ye, Zi-Han
|
|
|
14 |
9 |
p.
|
artikel
|
| 14 |
Simvastatin-romidepsin combination kills bladder cancer cells synergistically
|
Okubo, Kazuki
|
|
|
14 |
9 |
p.
|
artikel
|
| 15 |
SOS1 promotes epithelial-mesenchymal transition of Epithelial Ovarian Cancer(EOC) cells through AKT independent NF-κB signaling pathway
|
Cheng, Min
|
|
|
14 |
9 |
p.
|
artikel
|
| 16 |
Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage
|
Niu, Li-Ting
|
|
|
14 |
9 |
p.
|
artikel
|
| 17 |
The spontaneous remission of cancer: Current insights and therapeutic significance
|
Radha, Gudapureddy
|
|
|
14 |
9 |
p.
|
artikel
|
| 18 |
TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib
|
Yu, Ruofei
|
|
|
14 |
9 |
p.
|
artikel
|
Tijdschrift beschrijving